DentalGoodNews|Dental Credible Information Platform


香港医疗券大湾区试点机构申领1978万港元,爱康健口腔占77%

 
Issuing time:2025-04-12 16:46Author:编辑部
image.png

*图源:香港特别行政区立法会

近日,香港特别行政区立法会公布《审核2025-26年度开支预算管制人员的答复》,当中涉及2024年6月推行的“长者医疗券大湾区试点计划”的相关情况。

image.png

*图源:香港特别行政区立法会

数据显示,截至去年底,大湾区医疗机构共计77918宗医疗券申领,其中首批7家试点机构为15468宗,占比19.9%。试点机构中包含两家牙科服务机构,希玛医疗集团旗下的深圳爱康健口腔医院共收8903宗申领,占试点机构总申领数的57.6%;深圳紫荊口腔门诊部/深圳朱胜吉口腔门诊部共收到210宗申领。

image.png

*图源:香港特别行政区立法会

在申领金额方面,大湾区医疗机构共计申领3933.9万港元,其中7家试点机构的申领金额为1978.2万港元,占比50.3%。在试点机构中,深圳爱康健口腔医院累计申领金额1526.4万港元,成为7间试点机构中申领金额最高的,占试点机构总申领金额的77.2%。

据香港明报报道,希玛医疗首席策略及投资总监陈永基分析称,由于该公司地处口岸附近,且品牌为香港市民所熟悉,吸引了大量港人选择北上就医。他预估,试点机构全年医券申领总额可能达到5000万元,仅为近年来香港医疗券每年约33亿元申领总额的“冰山一角”。他表示,香港公立医院需长期轮候,香港和内地医疗服务的“深度融合”趋势是合理的。

香港牙医学会前会长王志伟指出,跨境医疗券申领规模虽未达预期,但已对本地市场形成冲击。他估算,本地牙科业务量较北上就医热潮前下降达双位数百分比。他特别强调两地经营规则的差异:香港牙医执业受严格宣传限制,而内地医疗机构可进行市场化推广,形成“不公平竞争”局面。

现任会长陈超余则认为,随着患者对两地牙医服务质量的认识提高,市场竞争将逐步趋于平衡,建议通过市场机制自然调节市民就医意向。

Member Trending Reads

Member Trending Reads

副标题

Full - mouth denture restoration is included in medical insurance. The industry concentration is at a low level, and there is huge room for integration. Are you ready to embrace new opportunities?
Regulation: Not to restrict growth, but to weed out bad apples & protect good ones—let quality firms shine in fair competition!
"Cooling Momentum, Unwavering Resilience" – The Dental Industry Is Marching Toward "Quality Restoration"!
California's New Bill Sets Clear Boundaries for Dentists' Decision-Making Authority: How to Balance Clinical Autonomy Amid the Capitalization Wave?
Mental Health: A Casualty of the Healthcare System — Who Foots the Bill for Practitioners’ Physical & Mental Well-Being?
National Dental Expansion Rebounds | 940 Net New (Sep)—What’s the Future Potential?
Standardized Implants → Millimeter-Level Orthognathic Bone Resection: Robots Reshaping Dental Surgery’s Execution Logic & Tech Boundaries!
【GOODNEWS】 Content for industry reference only (based on public info & professional judgment); not for decision-making. Readers bear full responsibility for their own judgment and risks. Copyright © This Platform. Unauthorized reproduction & commercial use prohibited. Errata, contributions & cooperation: Contact customer service via WeChat:HDSW_001
✉️
Subscribe to Our
Newsletter
We curate important stories and exclusive insights, delivered straight to your inbox.
In-depth analysis · Exclusive content · Fast-moving news
1
Contact Us


Cooperation & Contact: haodeya@dongxizixun.com
Industry Updates

Industry Updates

副标题